Related references
Note: Only part of the references are listed.Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry
Alexandra Simbrich et al.
DRUG SAFETY (2021)
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema
A. L. Bosma et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Opportunities and challenges associated with the evaluation of chimeric antigen receptor T cells in real-life
Eoin McGrath et al.
CURRENT OPINION IN ONCOLOGY (2020)
Patient Registries: An Underused Resource for Medicines Evaluation: Operational proposals for increasing the use of patient registries in regulatory assessments
Patricia McGettigan et al.
DRUG SAFETY (2019)
Orphan drugs: major development challenges at the clinical stage
Diogo A. Fonseca et al.
DRUG DISCOVERY TODAY (2019)
Key Learning Outcomes for Clinical Pharmacology and Therapeutics Education in Europe: A Modified Delphi Study
David J. Brinkman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Drug Registries and Approval of Drugs: Promises, Placebo, or a Real Success?
Carla J. Jonker et al.
CLINICAL THERAPEUTICS (2018)
Imposed registries within the European postmarketing surveillance system: Extended analysis and lessons learned for regulators
Alexandra Pacurariu et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2018)
Recommendations for Improving the Quality of Rare Disease Registries
Yllka Kodra et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2018)
Registries in European post-marketing surveillance: a retrospective analysis of centrally approved products, 2005-2013
Jacoline C. Bouvy et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
The impact of clinical trial monitoring approaches on data integrity and cost-a review of current literature
Rasmus Olsen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Impact of source data verification on data quality in clinical trials: an empirical post hoc analysis of three phase 3 randomized clinical trials
Jeppe Ragnar Andersen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
The European Cystic Fibrosis Society Patient Registry: valuable lessons learned on how to sustain a disease registry
Laura Viviani et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
Share Paper
